Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
analysts
Marketing
RFK Jr.'s 'biggest threat' to pharma is possible ad ban: analyst
RFK Jr. has previously expressed a desire to ban DTC pharma ads in the U.S.—which is one of only two countries in the world where such ads are legal.
Andrea Park
Nov 25, 2024 10:50am
New CKD drugs are promising, but not yet disruptive: report
Jun 26, 2024 10:45am
ALS market to grow 15% by end of decade: report
Jun 13, 2024 11:20am
Sanofi, GSK and Novo benefit from currency changes: analyst
Oct 21, 2022 9:21am
Pfizer's Paxlovid came up short in a COVID prophylaxis study
May 2, 2022 10:00am
Novartis hires Bernstein analyst Ronny Gal as new M&A czar
Apr 26, 2022 3:11am
